Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) | Zendy

Matteo Bassetti | Zendy; Antonio Vena | Zendy; Daniele Roberto Giacobbe | Zendy; Marco Falcone | Zendy; Giusy Tiseo | Zendy; Maddalena Giannella | Zendy; Renato Pascale | Zendy; Marianna Meschiari | Zendy; Margherita Digaetano | Zendy; Alessandra Oliva | Zendy; Cristina Rovelli | Zendy; Novella Carannante | Zendy; Angela Raffaella Losito | Zendy; Sergio Carbonara | Zendy; Michele Fabiano Mariani | Zendy; Antonio Mastroianni | Zendy; Gioacchino Angarano | Zendy; Mario Tumbarello | Zendy; Carlo Tascini | Zendy; Paolo Grossi | Zendy; Claudio Maria Mastroianni | Zendy; Cristina Mussini | Zendy; Pierluigi Viale | Zendy; Francesco Menichetti | Zendy; Claudio Viscoli | Zendy; Alessandro Russo | Zendy; Stefano Verdenelli | Zendy; Silvia Fabiani | Zendy; Nadia Castaldo | Zendy; Davide Pecori | Zendy; Alessia Carnellutti | Zendy; Filippo Givone | Zendy; Elena Graziano | Zendy; Maria Merelli | Zendy; Barbara Cadeo | Zendy; Maddalena Peghin | Zendy; Pierlugi Viale | Zendy; Anna Maria Cattelan | Zendy; Ludovica Cipriani | Zendy; Davide Coletto | Zendy; Gianluca Russo | Zendy; Maria Rosa Ciardi | Zendy; Camilla Ajassa | Zendy; Tiziana Tieghi | Zendy; Francesca Raffaelli | Zendy; Stefania Artioli | Zendy; Giorgia Caruana | Zendy; Roberto Luzzati | Zendy; Giulia Bontempo | Zendy; Nicola Petrosillo | Zendy; Alessandro Capone | Zendy; Giuliano Rizzardini | Zendy; Massimo Coen | Zendy; M Gambacorti Passerini | Zendy; Giuliana Guadagnino | Zendy; Filippo Urso | Zendy; Guglielmo Borgia | Zendy; Ivan Gentile | Zendy; Alberto Enrico Maraolo | Zendy; Massimo Crapis | Zendy; Sergio Venturini | Zendy; Giustino Parruti | Zendy; Francesca Trave | Zendy; Massimo Girardis | Zendy; Antonio Cascio | Zendy; Claudia Gioè | Zendy; Marco Anselmo | Zendy; Emanuele Malfatto | Zendy

Open Access

Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)

Author(s) -

Matteo Bassetti,

Antonio Vena,

Daniele Roberto Giacobbe,

Marco Falcone,

Giusy Tiseo,

Maddalena Giannella,

Renato Pascale,

Marianna Meschiari,

Margherita Digaetano,

Alessandra Oliva,

Cristina Rovelli,

Novella Carannante,

Angela Raffaella Losito,

Sergio Carbonara,

Michele Fabiano Mariani,

Antonio Mastroianni,

Gioacchino Angarano,

Mario Tumbarello,

Carlo Tascini,

Paolo Grossi,

Claudio Maria Mastroianni,

Cristina Mussini,

Pierluigi Viale,

Francesco Menichetti,

Claudio Viscoli,

Alessandro Russo,

Stefano Verdenelli,

Silvia Fabiani,

Nadia Castaldo,

Davide Pecori,

Alessia Carnellutti,

Filippo Givone,

Elena Graziano,

Maria Merelli,

Barbara Cadeo,

Maddalena Peghin,

Pierlugi Viale,

Anna Maria Cattelan,

Ludovica Cipriani,

Davide Coletto,

Gianluca Russo,

Maria Rosa Ciardi,

Camilla Ajassa,

Tiziana Tieghi,

Francesca Raffaelli,

Stefania Artioli,

Giorgia Caruana,

Roberto Luzzati,

Giulia Bontempo,

Nicola Petrosillo,

Alessandro Capone,

Giuliano Rizzardini,

Massimo Coen,

M Gambacorti Passerini,

Giuliana Guadagnino,

Filippo Urso,

Guglielmo Borgia,

Ivan Gentile,

Alberto Enrico Maraolo,

Massimo Crapis,

Sergio Venturini,

Giustino Parruti,

Francesca Trave,

Massimo Girardis,

Antonio Cascio,

Claudia Gioè,

Marco Anselmo,

Emanuele Malfatto

Publication year - 2020

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofaa139

Subject(s) - medicine , odds ratio , septic shock , pneumonia , confidence interval , urinary system , gastroenterology , surgery , sepsis

Data show that C/T could be a valid option in empiric and/or targeted therapy in patients with severe infections caused by ESBL-producing . Clinicians should be aware of the risk of clinical failure with standard-dose C/T therapy in septic patients receiving CRRT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research